Description

(3R,12aβ)-1,2,3,4aβ,5,6,6a,12,12a,12b-Decahydro-3α-(1-methyl-1-hydroxyethyl)-6aα,12bα-dimethyl-9-[(1R,2R,3S)-1,3-dimethyl-2-acetoxypentyl]pyrano[3,2-a]xanthene-8,11,12β-triol is a complex, high-purity diterpenoid derivative with a defined stereochemistry, making it a valuable advanced pharmaceutical intermediate for research and development. Its intricate molecular architecture is critical for synthesizing novel bioactive compounds, particularly in the field of medicinal chemistry. This product is essential for pharmaceutical R&D laboratories and fine chemical manufacturers focused on developing new therapeutic agents.

Application

• Pharmaceutical Intermediate: Key building block for the synthesis of novel drug candidates, especially in oncology and anti-inflammatory research.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to explore and optimize biological activity.
• Reference Standard: Serves as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.
• Biochemical Research: Investigated for its potential interactions with specific enzymes or cellular pathways due to its diterpenoid core.
• Fine Chemical Synthesis: Employed in multi-step organic syntheses to construct complex natural product analogs or specialized chiral molecules.

Basic Information

Product Name	(3R,12aβ)-1,2,3,4aβ,5,6,6a,12,12a,12b-Decahydro-3α-(1-methyl-1-hydroxyethyl)-6aα,12bα-dimethyl-9-[(1R,2R,3S)-1,3-dimethyl-2-acetoxypentyl]pyrano[3,2-a]xanthene-8,11,12β-triol
CAS No.	41059-86-3
Molecular Formula	C₃₄H₅₂O₈
Molecular Weight	588.78 g/mol
Synonyms	Taxinine M; 2-Deacetoxytaxinine J; 10-Deacetyl-2-debenzoyltaxinine J; (1S,2S,3R,4S,7S,9S,10R,12S)-4,12-Diacetoxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl 3-methylbutanoate; 5β,20-Epoxy-1β,13α-dihydroxy-4α,10β-diacetoxy-7β,9α,11α-trihydroxytax-11-en-9-one; A derivative of Taxinine
EINECS	Contact for details

Quality Control

Our (3R,12aβ)-1,2,3,4aβ,5,6,6a,12,12a,12b-Decahydro-3α-(1-methyl-1-hydroxyethyl)-6aα,12bα-dimethyl-9-[(1R,2R,3S)-1,3-dimethyl-2-acetoxypentyl]pyrano[3,2-a]xanthene-8,11,12β-triol is produced under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and MS, to ensure it meets the stringent requirements for pharmaceutical research. Certificates of Analysis (COA) detailing all specifications are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as specified on the label or COA. This compound may be hygroscopic (moisture-sensitive); keep the container tightly sealed in a dry environment.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 95.0%
Related Substances (HPLC)	Total impurities ≤ 5.0% Any single unknown impurity ≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Water Content (KF)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.